Congratulations to Shaira Kee for the acceptance of her co-first author paper in the Cell Communication and Signaling. Her paper is entitled “eNAMPT/TLR4 signaling drives PAH cellular phenotypic switching and lung vascular remodeling” and is a collaboration with Dr. Skip Garcia‘s lab. 
This paper shows that an eNAMPT monoclonal antibody significantly reduces the activity of multiple pulmonary arterial hypertension (PAH) pathways in mice. Since this antibody is currently in Phase 2A clinical trials for ARDS, these results show promise for future halting or reversing PAH in patients.
Paper availability: [journal web site]
Congratulations Shaira!